Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Paymentus Holdings

Benzinga's Top Ratings Upgrades, Downgrades For September 26, 2022

Why These Paymentus Analysts Are Lowering Price Targets After Q2 Earnings

Why These Paymentus Analysts Are Lowering Price Targets After Q2 Earnings

Cloud based bill payment company Paymentus Holdings (NYSE: PAY) saw shares fall after reporting second-quarter financial results after the market close Wednesday. Analysts are sizing up the company’s guidance and contract delays.

12 Information Technology Stocks Moving In Thursday's Intraday Session

12 Information Technology Stocks Moving In Thursday's Intraday Session

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2022

Paymentus Holdings Earnings Perspective: Return On Capital Employed

Pulled from Benzinga Pro data, Paymentus Holdings (NYSE:PAY) showed a loss in earnings since Q4, totaling $1.72 million. Sales, on the other hand, increased by 7.93% to $116.70 million during Q1.

Analyst Ratings for Paymentus Holdings

Paymentus Holdings (NYSE:PAY) has observed the following analyst ratings within the last quarter:

Paymentus Holdings's Return On Capital Employed Overview

According to Benzinga Pro, during Q4, Paymentus Holdings (NYSE:PAY) earned $4.67 million, a 1005.45% increase from the preceding quarter. Paymentus Holdings also posted a total of $108.13 million in sales, a 6.35% increase since Q3.

inkl

Read news from The Economist, FT, and more,
with one subscription

Where Paymentus Holdings Stands With Analysts

Where Paymentus Holdings Stands With Analysts

Analysts have provided the following ratings for Paymentus Holdings (NYSE:PAY) within the last quarter:

1

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Neurocrine Biosciences

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play